Home > Financial Ratios > WANBURY

WANBURY
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 9.34203.06-34.5980.29-16.93

What is the latest Core EBITDA Growth ratio of WANBURY ?

The latest Core EBITDA Growth ratio of WANBURY is 9.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20259.34
Mar2024203.06
Mar2023-34.59
Mar202280.29
Mar2021-16.93

How is Core EBITDA Growth of WANBURY Trending?

Years Core EBITDA Growth % Change
Mar2025 9.34
-95.40
Mar2024 203.06
Positive
Mar2023 -34.59
Negative
Mar2022 80.29
Positive
Mar2021 -16.93 -

Other Financial Ratios of WANBURY


Compare Core EBITDA Growth ratio of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹679.4 Cr -2.5% -22.8% -20.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,483.0 Cr -3.2% -7.8% 9% Stock Analytics
DIVIS LABORATORIES ₹249,248.0 Cr 1% 0.9% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,822.0 Cr -1.8% -4.8% 32.2% Stock Analytics
CIPLA ₹105,427.0 Cr -3.1% -6.5% -12.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,492.3 Cr -1.7% 3.1% -3.5% Stock Analytics


WANBURY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

-2.5%

-22.8%

-20.6%

SENSEX

-1.2%

-6.4%

-10.8%


You may also like the below Video Courses